This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Brandeis University, The Brigham and Women's Hospital, Inc., University of Georgia Research Foundation Inc. Active years: 2015-2018.
Company Filing History:
2 out of 268 
2 out of 1,422 
2 out of 870 Years Active: 2015-2018
Title: Innovations by Boris Striepen
Introduction
Boris Striepen is a notable inventor based in Athens, GA, who has made significant contributions to the field of pharmaceutical sciences. He holds two patents that focus on innovative methods for treating gastrointestinal microbial infections in mammals. His work is particularly relevant in the context of developing targeted therapies against parasitic infections.
Latest Patents
Striepen's latest patents include compounds and methods for treating mammalian gastrointestinal microbial infections. These patents describe compounds and pharmaceutically acceptable salts and prodrugs that serve as inhibitors of IMPDH. In certain embodiments, these compounds selectively inhibit a parasitic IMPDH versus a host IMPDH. The invention also provides pharmaceutical compositions comprising one or more of these compounds. Furthermore, it relates to methods of treating various parasitic and bacterial infections in mammals. The compounds may be used alone or in combination with other therapeutic or prophylactic agents, such as anti-virals, anti-inflammatory agents, antimicrobials, and immunosuppressants.
Career Highlights
Boris Striepen has had a distinguished career, working with reputable institutions such as Brandeis University and the University of Georgia Research Foundation, Inc. His research has focused on the intersection of microbiology and pharmacology, leading to advancements in treatment options for gastrointestinal infections.
Collaborations
Striepen has collaborated with notable colleagues, including Lizbeth K. Hedstrom and Gregory D. Cuny. These collaborations have contributed to the depth and breadth of his research, enhancing the impact of his innovations.
Conclusion
Boris Striepen's work exemplifies the importance of innovation in the field of medicine, particularly in developing targeted treatments for infections. His patents reflect a commitment to advancing healthcare through scientific research and collaboration.